Heijtink et al., 1985 - Google Patents

Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine

Heijtink et al., 1985

Document ID: 2521470655688901008
Author: Heijtink R; Kruining J; Bakker M; Schalm S
Publication year: 1985
Publication venue: Antiviral Research

External Links

Cited by

Snippet

Thirty-one individuals (health care workers) were vaccinated with recombinant hepatitis B vaccine (10 µg dose) and their immune response (anti-HBs) was compared to that of twenty- five health care workers after vaccination with plasma-derived vaccine (20 µg dose) …

Continue reading at www.sciencedirect.com (other versions)

229960005486 vaccines 0 title abstract description 63

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form

Similar Documents

Publication	Publication Date	Title
Zajac et al.	1986	Overview of clinical studies with hepatitis B vaccine made by recombinant DNA
Andre	1990	Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine
Zuckerman	1996	Nonresponse to hepatitis B vaccines and the kinetics of anti‐HBs production
Dienstag et al.	1982	Hepatitis B vaccine administered to chronic carriers of hepatitis B surface antigen
Couillin et al.	1999	Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens
Oon et al.	1995	Molecular epidemiology of hepatitis B virus vaccine variants in Singapore
Lo et al.	2005	Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B
Clements et al.	1994	Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2+ S antigens
Idilman et al.	2002	The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C
Hollinger et al.	1986	Anti-HBs responses to vaccination with a human hepatitis B vaccine made by recombinant DNA technology in yeast
Pride et al.	1998	Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene®, a hepatitis B vaccine containing pre-S1, pre-S2 and S gene products
Krugman et al.	1987	Hepatitis B vaccine: prospects for duration of immunity
Heijtink et al.	1985	Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine
Odaka et al.	1988	Comparative immunogenicity of plasma and recombinant hepatitis B virus vaccines in homosexual men
Flehmig et al.	1990	Simultaneous vaccination for hepatitis A and B
Wang et al.	2007	Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity
Hanson et al.	1984	Cell-mediated immunity to hepatitis B surface antigen in man
Miskovsky et al.	1991	Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2+ S antigens
Geissler et al.	1997	Chronic ethanol effects on cellular immune responses to hepatitis B virus envelope protein: an immunologic mechanism for induction of persistent viral infection in alcoholics
Heintges et al.	2001	Combination therapy of active HBsAg vaccination and interferon-α in interferon-α nonresponders with chronic hepatitis B
Hui et al.	2005	Advances in immunomodulating therapy of HBV infection
Goh et al.	1995	Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults
Menne et al.	2007	Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein
Akbar et al.	2004	Vaccine therapy for hepatitis B virus carrier
Bucher et al.	1994	Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster